Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
22.67
+0.80 (3.66%)
At close: Aug 13, 2025, 4:00 PM
22.77
+0.10 (0.44%)
Pre-market: Aug 14, 2025, 4:43 AM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $13.88 billion as of August 13, 2025. Its market cap has decreased by -26.02% in one year.
Market Cap
13.88B
Enterprise Value
11.14B
1-Year Change
-26.02%
Ranking
Category
Stock Price
$22.67
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $13.88B, an increase of 3,201.44%. That is a compound annual growth rate of 30.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 14.03B | 1.59% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |